首页> 美国卫生研究院文献>Journal of Oncology >Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma

【2h】

Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma

机译：三DNA甲基化生物标志物在软组织肉瘤患者中的预后价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Journal of Oncology
作者
Yuxiao Chen; Rui Zhu; Min Chen; Wenna Guo; Xin Yang; Xin-Jian Xu; Liucun Zhu;
展开▼
作者单位

展开▼
年(卷),期 2020(2020),-1
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma [J] . Yuxiao Chen, Rui Zhu, Min Chen, Journal of oncology . 2020,第1期

机译：软组织Sarcoma患者三-DNA甲基化生物标志物的预后价值
2. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) [J] . Lindner Lars H., Litiere Saskia, Sleijfer Stefan, International Journal of Cancer =: Journal International du Cancer . 2018,第12期

机译：软组织肉瘤患者肺转移患者的预后因素仅接受一线化疗，探讨欧洲癌症软组织和骨肉瘤组研究和治疗组织的探索性，回顾性分析（EORTC-STBSG）
3. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). [J] . Sleijfer S, Ouali M, van Glabbeke European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2010,第1期

机译：成年晚期软组织肉瘤成年患者接受一线含异环磷酰胺一线化疗的结果的预后和预测因素：对欧洲软组织癌症研究和治疗组织和骨肉瘤组织（EORTC）进行的大系列研究的回顾性分析-STBSG）。
4. OPTIMIZING METRONOMIC CHEMOTHERAPY USING TUMOR BIOMARKERS IN DOGS WITH SOFT TISSUE SARCOMA [C] . Jenna Burton, Dahlia Rice, Jesse Harper, Annual Conference of the Veterinary Cancer Society . 2009

机译：用软组织肉瘤患者肿瘤生物标志物优化元组化疗
5. Near-Infrared Spectroscopy to Assess Exercise-Induced Changes in Skeletal Muscle Oxygenation in Patients with Soft Tissue Sarcoma: A Preliminary Investigation [D] . Hoselton, Andrew Lewis. 2021

机译：近红外光谱，评估软组织肉瘤患者骨骼肌氧合的运动诱导的变化：初步调查
6. Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study [O] . Thomas Brodowicz, Bernadette Liegl-Atzwanger, Nicolas Penel, 2020

机译：评估先进软组织肉瘤患者的预测和预测生物标志物：Regosarc学习
7. Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma [O] . Yuxiao Chen, Rui Zhu, Min Chen, 2020

机译：软组织Sarcoma患者三-DNA甲基化生物标志物的预后价值

Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma

著录项

引文网络

相似文献

相关主题

期刊订阅